Plasma asymmetric dimethylarginine predicts restenosis after coronary angioplasty

INTRODUCTION: Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of endothelial nitric oxide synthase. Asymmetric dimethylarginine may influence the process of restenosis after coronary angioplasty. The aim of the study was to determine if initial plasma ADMA level could predi...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Derkacz, Arkadiusz, Protasiewicz, Marcin, Poręba, Rafał, Doroszko, Adrian, Poręba, Małgorzata, Antonowicz-Juchniewicz, Jolanta, Andrzejak, Ryszard, Szuba, Andrzej
Формат: Artigo
Язык:Inglês
Опубликовано: Termedia Publishing House 2011
Предметы:
Clinical Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3258748/
https://ncbi.nlm.nih.gov/pubmed/22295027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2011.23410
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы